Thilo Schroeder

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Zurich, Switzerland
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Darren DeStefano, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Thilo Schroeder

Form 4 holding Director

Revolution Medicines, Inc.

Security class
Common Stock
Shares / value
3,590,313
Estimated value
$165,154,398
Report date
05 Dec 2024
Price
$46.00
Ownership
By Nextech V Oncology S.C.S., SICAV-SIF
Form 4 holding Director

Revolution Medicines, Inc.

Security class
Common Stock
Shares / value
2,096,612
Estimated value
$96,444,152
Report date
05 Dec 2024
Price
$46.00
Ownership
By Nextech Crossover I SCSP
Form 4 holding Director

Revolution Medicines, Inc.

Security class
Common Stock
Shares / value
1,153,293
Estimated value
$53,051,478
Report date
05 Dec 2024
Price
$46.00
Ownership
By Nextech VI Oncology SCSp
Form 4 holding Director

Revolution Medicines, Inc.

Security class
Common Stock
Shares / value
760,869
Estimated value
$34,999,974
Report date
05 Dec 2024
Price
$46.00
Ownership
By Nextech VIII SCSP
Form 4 holding Director

PMV Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
1,101,283
Estimated value
$2,455,861
Report date
06 Oct 2021
Price
$2.23
Ownership
Indirect

Insider Reports Filed by Thilo Schroeder

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .